Hematology Analyzers Market Share Estimated to Reach US$ $3.94 Billion with an 7.3% CAGR by 2030 | IDEXX Laboratories, Inc.

According to Allied Market Research, the global hematology analyzer market is expected to reach $3.94 billion by 2030, growing at a CAGR of 7.3% from 2021 to 2030. Rise in the prevalence of blood disorders and growth in demand for automated hematology analyzers along with surge in inclination toward high sensitivity hematology analyzers have boosted the growth of the market growth. In addition, the rapid technological advancements in hematology analyzers supplement the market growth. The rapid launch of the novel, technologically advanced hematology analyzers has unlocked new opportunities.

For Right Perspective and Competitive Insights, Get Sample Report at:

https://www.alliedmarketresearch.com/request-sample/13999

Advent of hematology analyzers, healthcare professionals could get accurate results in a short period. The feature of programmable automated alarm systems in hematology analyzers increased their demand drastically. Currently, these devices are used to detect and monitor diseases. The rise in the number of patients suffering from blood cancer, blood clots, and hemophilia has increased the demand for hematology analyzers.

Hematology analyzers are automated systems designed to count leucocytes, platelets, and red cells in the blood. The technology in hematology analyzers has evolved at a rapid pace over a very short period. Currently, hematology analyzers can determine the level of hemoglobin and hematocrit. Earlier, complete blood count (CBC) was examined manually by laboratory technicians which involved human errors.

Impact of COVID-19 Pandemic on the Hematology Analyzer Market

A few subdomains of healthcare industry had to pause or shut their operations due to lockdown and lack of workforce.

The pandemic affected the hematology analyzer market positively, attributing to an increase in focus on the hematology parameters to assess the COVID-19 infection.

Currently, there are a few jobs where clinicians are mandatory such as transferring blood samples from the collecting tube to the instrument. However, in the future, hematology analyzers would limit human involvement as much as possible to eliminate the risk of aerosols released while collecting the tube. The device operator merely needs to place the caped collection tube in the sample carrier and it will automatically enter the device for analysis. With the advent of the Internet of Things (IoT), these devices will receive major upgrades. The healthcare professionals would receive the reports and updates promptly on a regular basis. The advent of new technologies would make hematology analyzers safer, more accurate, and much easier to handle.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.